DoW Lung Cancer Translational Research Award
About
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis. Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 – Pilot clinical trials of novel interventions.
The DoW Lung Cancer Translational Research Award is designed for researchers and research institutions committed to advancing lung cancer treatment through translational science. This program supports the critical bridge between laboratory discoveries and real-world clinical applications, funding projects that transform promising lung cancer research ideas into therapies that can help patients. The award is ideal for research teams with innovative approaches to lung cancer treatment who are ready to move beyond basic research into applied settings. Whether your team is conducting advanced preclinical work with strong clinical potential or preparing to launch pilot clinical trials of novel interventions, this funding mechanism provides the resources needed to accelerate progress. The program emphasizes research that aligns with the fiscal year 2026 Lung Cancer Research Program areas of emphasis, ensuring your work contributes to priority scientific challenges. By supporting translational research at this critical stage, the DoW Lung Cancer Translational Research Award enables researchers to reduce the time between scientific discovery and patient benefit, ultimately improving outcomes for lung cancer patients nationwide.
Funding Facts
● Applications openDeadline
September 2, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by funding level and project scope
Deadline
2026-09-02
Grant Type
federal
Application Cycle
Annual
Best For
Research institutions and academic medical centers conducting translational lung cancer research
Frequently Asked Questions
Who is eligible for DoW Lung Cancer Translational Research Award?
Specific eligibility criteria were not provided in the available program information. Eligible organizations typically include research institutions, academic medical centers, and nonprofit research organizations. For precise eligibility requirements, including institutional qualifications and investigator credentials, visit the official DoW Lung Cancer Research Program website or contact the program administrators directly.
How much funding does DoW Lung Cancer Translational Research Award provide?
Specific funding amounts for FY26 are not currently available. Award amounts typically vary depending on the project scope and funding level selected. For detailed information about funding levels and award ranges, consult the official program solicitation or contact the Department of War grant office directly.
How do I apply for DoW Lung Cancer Translational Research Award?
Applications are submitted through the official DoW grant system. The program accepts applications under two funding levels: Level 1 for advanced or late-stage preclinical work and correlative studies, and Level 2 for pilot clinical trials of novel interventions. Complete application guidelines, required documentation, and submission procedures are available on the official DoW Lung Cancer Research Program website. The application deadline for FY26 is September 2, 2026.
What can DoW Lung Cancer Translational Research Award funding be used for?
This award supports advanced translational research that moves promising lung cancer concepts toward clinical application. Funding Level 1 supports advanced or late-stage preclinical research and correlative studies, while Funding Level 2 supports pilot clinical trials of novel interventions. Projects must address at least one of the FY26 Lung Cancer Research Program areas of emphasis. For specific allowable expenses and research scope details, review the official program solicitation.
Last updated: July 5, 2026